These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11150412)

  • 1. Hyaluronidase can be used to reduce interstitial edema in the presence of heparin.
    Johnsson C; Hällgren R; Tufveson G
    J Cardiovasc Pharmacol Ther; 2000 Jul; 5(3):229-36. PubMed ID: 11150412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronidase ameliorates rejection-induced edema.
    Johnsson C; Hällgren R; Elvin A; Gerdin B; Tufveson G
    Transpl Int; 1999; 12(4):235-43. PubMed ID: 10460867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edema treatment during cardiac allograft rejection.
    Johnsson C; Hällgren R; Lindbom LO; Tufveson G
    J Heart Lung Transplant; 1999 Dec; 18(12):1238-42. PubMed ID: 10612385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of intragraft pressure of rejecting organs: increased tissue pressure can be reduced by hyaluronidase therapy.
    Johnsson C; Tufveson G; Hällgren R
    Transplantation; 2000 Dec; 70(11):1575-80. PubMed ID: 11152218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronidase treatment of graft pancreatitis in rats: marked effects on the blood perfusion of the transplanted pancreas.
    Jansson L; Tufveson G; Bodin B; Emanuelsson C
    Scand J Immunol; 2010 Nov; 72(5):416-24. PubMed ID: 21039736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of hyaluronan and tissue edema in experimental myocardial infarction.
    Waldenström A; Martinussen HJ; Gerdin B; Hällgren R
    J Clin Invest; 1991 Nov; 88(5):1622-8. PubMed ID: 1939649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronidase reduces intragraft pressure of rejecting tissue.
    Johnsson C; Hällgren R; Tufveson G
    Transplant Proc; 2001 Jun; 33(4):2484. PubMed ID: 11406221
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyaluronan affects extravascular water in lungs of unanesthetized rabbits.
    Bhattacharya J; Cruz T; Bhattacharya S; Bray BA
    J Appl Physiol (1985); 1989 Jun; 66(6):2595-9. PubMed ID: 2745321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantation edema in heart allografts in rats.
    Hällgren R; Gerdin B; Tengblad A; Tufveson G
    J Clin Invest; 1990 Mar; 85(3):668-73. PubMed ID: 2312720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mystixin peptides reduce hyaluronan deposition and edema formation.
    Stair S; Carlson KW; Shuster S; Wei ET; Stern R
    Eur J Pharmacol; 2002 Aug; 450(3):291-6. PubMed ID: 12208322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The graft content of hyaluronan is increased during xenograft rejection.
    Lorant T; Tufveson G; Johnsson C
    Xenotransplantation; 2004 May; 11(3):269-75. PubMed ID: 15099207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hyaluronan--a potential marker of cardiac allograft rejection?
    Johnsson C; Tufveson G
    J Heart Lung Transplant; 2006 May; 25(5):544-9. PubMed ID: 16678033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial fluid pressure in human osteosarcoma xenografts: significance of implantation site and the response to intratumoral injection of hyaluronidase.
    Brekken C; Bruland ØS; de Lange Davies C
    Anticancer Res; 2000; 20(5B):3503-12. PubMed ID: 11131654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of rejection-induced diastolic abnormalities in rat cardiac allografts with inducible nitric oxide synthase inhibition.
    Soto PF; Jia CX; Rabkin DG; Hart JP; Carter YM; Sardo MJ; Hsu DT; Fisher PE; Pinsky DJ; Spotnitz HM
    J Thorac Cardiovasc Surg; 2000 Jul; 120(1):39-46. PubMed ID: 10884653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimentally-induced warm renal ischemia induces cortical accumulation of hyaluronan in the kidney.
    Johnsson C; Tufveson G; Wahlberg J; Hällgren R
    Kidney Int; 1996 Oct; 50(4):1224-9. PubMed ID: 8887281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronidase reduces human breast cancer xenografts in SCID mice.
    Shuster S; Frost GI; Csoka AB; Formby B; Stern R
    Int J Cancer; 2002 Nov; 102(2):192-7. PubMed ID: 12385018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hyaluronan in acute pancreatitis.
    Johnsson C; Hällgren R; Tufveson G
    Surgery; 2000 Jun; 127(6):650-8. PubMed ID: 10840360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of rat liver graft function after storage in University of Wisconsin solution containing testicular hyaluronidase.
    Papanikolaou V; Vrochides D; Gakis D; Patsiaoura K; Margari P; Dogramatzi F; Antoniades A; Heldin P
    Liver Transpl; 2002 Nov; 8(11):1028-35. PubMed ID: 12424716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft. Relationship to the transplantation edema.
    Hällgren R; Gerdin B; Tufveson G
    J Exp Med; 1990 Jun; 171(6):2063-76. PubMed ID: 2191073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of hyaluronidase regulates its inhibition by heparin.
    Maksimenko AV; Petrova ML; Tischenko EG; Schechilina YV
    Eur J Pharm Biopharm; 2001 Jan; 51(1):33-8. PubMed ID: 11154901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.